The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.895
Bid: 0.87
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.05 (5.747%)
Open: 0.895
High: 0.895
Low: 0.895
Prev. Close: 0.895
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Twelfth Mandatory Redemption & Shareholder Update

24 Oct 2023 07:00

RNS Number : 0071R
JPEL Private Equity Limited
24 October 2023
 

JPEL Private Equity Limited

Ground Floor

Cambridge House

Le Truchot, St Peter Port

Guernsey, GY1 1WD

www.jpelonline.com

 

 

TWELFTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE

 

 

 

· JPEL WILL RETURN $6 MILLION TO SHAREHOLDERS

 

· REDEMPTION DATE 7 NOVEMBER 2023

 

· REDEMPTION REPRESENTS 14.7% OF US$ EQUITY SHAREHOLDER NET ASSET VALUE AT 30 SEPTEMBER 2023

 

· REDEMPTION REPRESENTS 23.3% OF JPEL's MARKET CAPITALIZATION AT 17 OCTOBER 2023

 

· Macroenvironment resulting in A POTENTIAL slowing OF realisation timing

 

 

* * *

 

GUERNSEY, 24 OCTOBER 2023

 

 

The Company is pleased to announce its twelfth Mandatory Redemption to US$ Equity Shareholders. The amount of the redemption will be $6 million or 14.7% of NAV at 30 September 2023 (approximately 23.3% of JPEL's market capitalization at 17 October 2023).

 

The $6 million capital return (the equivalent of approximately 3.7 million US$ Equity Shares) will be by way of a pro rata compulsory redemption of US$ Equity Shares at a price equal to the prevailing NAV per US$ Equity Share of $1.61 as at 30 September 2023 (being the most recent NAV per US$ Equity Share available as of the date of this announcement) for US$ Equity Shareholders on the register of members as at close of business on 7 November 2023 ("Record Date"). Unless circumstances require otherwise, this NAV will form the NAV per US$ Equity Share as of the date of redemption.

 

Payments of redemption proceeds are expected to be effected either through CREST (in the case of shares held in uncertificated form) or by cheque (in the case of shares held in certificated form) on or around 22 November 2023. Any share certificates for the balance of holdings of shares will also be despatched to shareholders on or around 21 November 2023.

 

The Company currently has 25,375,033 US$ Equity Shares in issue. All of the US$ Equity Shares redeemed on the redemption date will be cancelled and any fractions of shares will be rounded down to the nearest whole share.

 

The US$ Equity Shares will be disabled in CREST on the Record Date and the existing ISIN number GG00BPSMLX26 (the "Old ISIN") will expire. A new ISIN number GG00BS82YQ75 (the "New ISIN") in respect of the remaining US$ Equity Shares which have not been redeemed will be enabled and available for transactions on 8 November 2023 (the "Ex-date"). For the period up to and including the Record date, US$ Equity Shares will be traded under the Old ISIN and as such, a purchaser of such shares may have a market claim for the redemption proceeds following the activation of the New ISIN. CREST will automatically transfer any open transactions as at the redemption date to the New ISIN.

 

Inclusive of this Mandatory Redemption, JPEL will have returned $531.7 million to US$ Equity Shareholders, or approximately 111% and 138.9% of the Company's 31 October 2016 NAV and market capitalization. Please note that the prevailing NAV at the time of the Company's first mandatory redemption was 31 October 2016.

 

SHAREHOLDER UPDATE

 

As JPEL continues to run-off its portfolio organically, the Board would like to remind shareholders that it will revisit a variety of options once JPEL's NAV approaches approximately $30 million. As global markets continue to be affected by well documented macroeconomic factors, the JPEL portfolio may be impacted, similar to other private equity funds, in timing, valuation, or amounts of realisation activity. As a result, distributions in 2024 are likely to be unpredictable.

 

DIRECTOR'S INTERESTS

 

As of 24 October 2023, Sean Hurst and Tony Dalwood, Directors of the Company, owned 1,977 and 10,132 US$ Equity Shares, respectively. As a result of the Mandatory Redemption described above, Sean Hurst and Tony Dalwood are expected, immediately following the redemption date, to hold approximately 1,691 and 8,663 US$ Equity Shares, respectively.

 

 

* * *

 

 

LEI Number: 5493005M6GBE3DNJZ894

 

 

 

 

About JPEL Private Equity Limited

 

JPEL Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well-diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

ENQUIRIES:

 

FCF JPEL Management LLC

JPELClientService@fortress.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CASPPGGCUUPWGCW
Date   Source Headline
23rd Apr 20245:18 pmRNSDirector Declaration
15th Mar 20246:15 pmRNSNet Asset Value - December 2023
15th Mar 20246:03 pmRNSHalf-year Report - December 2023
15th Mar 20243:50 pmRNSHalf-year Report - 2023
6th Dec 20235:36 pmRNSDirector Declaration
6th Dec 20235:33 pmRNSAGM RESULTS 2023
9th Nov 202311:56 amRNS2023 AGM CIRCULAR
8th Nov 20237:00 amRNSCompletion of Twelfth Mandatory Redemption
24th Oct 20237:00 amRNSTwelfth Mandatory Redemption & Shareholder Update
20th Oct 202310:28 amRNSNet Asset Value - September 2023
21st Sep 20235:33 pmRNSNet Asset Value(s) - June 2023
21st Jun 20233:36 pmRNSDirectorate Change
12th May 20231:46 pmRNSNet Asset Value(s) - March 2023
28th Mar 20233:32 pmRNSHalf-year Report - 31 December 2022
14th Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 202311:05 amRNSSecond Price Monitoring Extn
14th Mar 202311:00 amRNSPrice Monitoring Extension
14th Mar 20239:05 amRNSSecond Price Monitoring Extn
14th Mar 20239:00 amRNSPrice Monitoring Extension
24th Feb 20234:22 pmRNSNet Asset Value(s) - December 2022
13th Feb 20234:51 pmRNSDirector Declaration
22nd Dec 20227:00 amRNSCompletion of Eleventh Mandatory Redemption
14th Dec 20227:00 amRNSELEVENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE
13th Dec 20225:09 pmRNSDirectorate Change
29th Nov 20224:33 pmRNSAGM Results 2022
9th Nov 20224:11 pmRNS2022 AGM CIRCULAR
27th Oct 20226:26 pmRNSNet Asset Value - September 2022
23rd Sep 20224:54 pmRNSAnnual Financial Report - 30 June 2022
13th Sep 20223:03 pmRNSNet Asset Value(s) - June 2022
13th Jul 202211:36 amRNSNet Asset Value(s) - May 2022
6th Jul 20224:26 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSUpdate to Shareholders
23rd Jun 20225:10 pmRNSNet Asset Value(s) - April 2022
17th May 20227:00 amRNSNet Asset Value(s) - March 2022
11th May 202211:27 amRNSNet Asset Value - February 2022
6th May 20227:00 amRNSNet Asset Value - January 2022
5th May 20225:39 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSPortfolio Update
11th Apr 202212:34 pmRNSCompletion of Tenth Mandatory Redemption
4th Apr 20227:00 amRNSTenth Mandatory Redemption
17th Mar 20225:35 pmRNSHalf-year Report - 31 December 2021
7th Mar 20229:44 amRNSNet Asset Value - December 2021
19th Jan 20221:47 pmRNSNet Asset Value - November 2021
22nd Dec 20214:24 pmRNSNet Asset Value - October 2021
23rd Nov 20212:13 pmRNSAGM Results 2021
16th Nov 20214:42 pmRNSNet Asset Value - September 2021
3rd Nov 202112:29 pmRNSNet Asset Value - August 2021
2nd Nov 20211:49 pmRNS2021 AGM CIRCULAR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.